Indication: Mildor moderate heart failure of ischemic or cardiomyopathic origin, in conjunction with digitalis, diuretics and ACE inhibitors, Hypertension: Monotherapy or in combination.Dosage & Administration:Initially 12.5 mg once daily, increased to 25 mg once daily; max. 50 mg daily single/divid..
Indication: EslicarTM (Eslicarbazepine acetate) is indicated as an add-on therapy for partial seizure with or without secondary generalization. Dosage & Administration:EslicarTM(Eslicarbazepine acetate) must be added to existing anticonvulsant therapy. The recommendedstarting dose is 400 mg once dai..
This product is a combination of two antihypertensive drugs: a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker), amlodipine besilate, and an angiotensin II receptor blocker, olmesartan medoxomil. The amlodipine component inhibits the transmembrane influx of calcium..
This product is a combination of two antihypertensive drugs: a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker), amlodipine besilate, and an angiotensin II receptor blocker, olmesartan medoxomil. The amlodipine component inhibits the transmembrane influx of calcium..